Patient selection and outcome in low-grade glioma surgeryInstitute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, NTNU, Trondheim, Norway; Department of Neurosurgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Neurovetenskaper. Department of Neurosurgery, University Hospital of Northern Sweden, Umeå, Sweden.
Department of Medical Sciences, Section of Neurosurgery, Uppsala University Hospital, Uppsala, Sweden.
Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway; Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
Department of Neurosurgery, Linköping University Hospital, Linköping, Sweden; Department of Biomedical and clinical Sciences, Linköping University, Linköping, Sweden.
Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Sciences, Skåne University Hospital, Lund, Sweden; Department of Neurosurgery, Skåne University Hospital, Lund, Sweden.
Department of Neurosurgery, University Hospital of North Norway, Tromsø, Tromsø, Sweden.
Department of Neurosurgery, Linköping University Hospital, Linköping, Sweden; Department of Biomedical and clinical Sciences, Linköping University, Linköping, Sweden.
Department of Neurosurgery, Skåne University Hospital, Lund, Sweden.
Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway; Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden; Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Copenhagen, Denmark.
Department of Neurosurgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Visa övriga samt affilieringar
2025 (Engelska)Ingår i: Frontiers in Oncology, E-ISSN 2234-943X, Vol. 15, artikel-id 1703756
Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Background and objectives: Maximal safe resection is the cornerstone of diffuse low-grade glioma (dLGG) management, although epidemiological data are limited. We aim to explore surgical selection, techniques, and outcomes in a population-based cohort.
Materials and methods: This study utilized a multi-center case series (9 out of 10 neurosurgical departments in Norway and Sweden) of all adults (≥18 years) with histopathologically verified supratentorial dLGG, WHO grade 2, undergoing primary surgery from 2012-2017. Complications within 30 days and neurological outcomes at 3 months were assessed. Pre- and postoperative MRIs were reviewed centrally, blinded to patient outcome and center.
Results: Of 517 included patients, 217 (41.7%) were female, and the mean (SD) age was 44.5 (15.0) years. Biopsy only was performed in 119 (23.0%) patients (13.8-38.9% across centers), and 398 (77.0%) underwent resection (61.1-86.2%). Intraoperative neurophysiological monitoring (IONM) was used in 142 (35.7%, 0-58.7%) resections. The biopsy-only patients were older (52.7 years vs. 42.1 years, P<.001), had larger tumors (56.6 ml vs. 31.9 ml, P<.001), and these tumors were more often eloquently located (86.6% vs. 56.5%, P<.001). The median (IQR) extent of resection (EOR) was 82.9% (63.3-97.7%), 69.7-100.0% across centers. The median (IQR) residual tumor was 4.6 ml (0.5-19.9 ml), 0.0-14.1 ml across centers. Age and histopathology were the most important predictors of EOR. New/worsened neurological deficits occurred in 165 patients (41.5%), 23.1-66.7% across centers, and persisted in 19 (4.8%, 0-22.7%) at 3 months after surgery. A complication was observed in 87 patients (21.4%, 0-31.7%), with 12 patients (3.1%, 0-9.8%) having grade III-IV complications.
Conclusions: We found that surgical selection was associated with age, tumor size, and location. The median EOR in a population-based cohort was 83%, with age and tumor biology being significant predictors. EOR did not correlate with higher risks or worse neurological outcomes. We provide an epidemiological perspective demonstrating a variation in surgical selection and techniques reflecting persistent controversy in dLGG management.
Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2025. Vol. 15, artikel-id 1703756
Nyckelord [en]
extent of resection, glioma, low-grade glioma, neurological deficits, neurosurgery, oncology, surgical outcomes
Nationell ämneskategori
Neurovetenskaper
Forskningsämne
neurokirurgi
Identifikatorer
URN: urn:nbn:se:umu:diva-246922DOI: 10.3389/fonc.2025.1703756ISI: 001636528100001PubMedID: 41395619Scopus ID: 2-s2.0-105025055762OAI: oai:DiVA.org:umu-246922DiVA, id: diva2:2017270
2025-11-282025-11-282026-03-20Bibliografiskt granskad